This would aid the volume of plasma collected per center, but also reduce blood donor screening. We also think CSL benefits from superior fractionation expertise and quality processes, enabling ...
Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback